Diabetes Enhances Periodontal Bone Loss through Enhanced Resorption and Diminished Bone Formation

Using a ligature-induced model in type-2 Zucker diabetic fatty (ZDF) rat and normoglycemic littermates, we investigated whether diabetes primarily affects periodontitis by enhancing bone loss or by limiting osseous repair. Diabetes increased the intensity and duration of the inflammatory infiltrate (P < 0.05). The formation of osteoclasts and percent eroded bone after 7 days of ligature placement was similar, while four days after removal of ligatures, the type 2 diabetic group had significantly higher osteoclast numbers and activity (P < 0.05). The amount of new bone formation following resorption was 2.4- to 2.9-fold higher in normoglycemic vs. diabetic rats (P < 0.05). Diabetes also increased apoptosis and decreased the number of bone-lining cells, osteoblasts, and periodontal ligament fibroblasts (P < 0.05). Thus, diabetes caused a more persistent inflammatory response, greater loss of attachment and more alveolar bone resorption, and impaired new bone formation. The latter may be affected by increased apoptosis of bone-lining and PDL cells.

[1]  A. Parfitt The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. , 1982, Metabolic bone disease & related research.

[2]  S. Rovin,et al.  The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. , 1966, Journal of periodontal research.

[3]  T. Suzuki,et al.  In vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  R. Kenworthy,et al.  Studies of a periodontal tissue lesion in the rat, untreated or treated with chlorhexidine digluconate. , 1981, Journal of clinical periodontology.

[5]  R. Williams,et al.  Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. , 1985, Science.

[6]  I. Lamster,et al.  Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. , 2004, Journal of periodontology.

[7]  E. Krall,et al.  Inflammation is More Persistent in Type 1 Diabetic Mice , 2005, Journal of dental research.

[8]  D. Graves,et al.  The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. , 2003, Journal of periodontology.

[9]  W. Knowler,et al.  Type 2 diabetes mellitus and periodontal disease. , 1990, Journal of the American Dental Association.

[10]  D. Graves,et al.  Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways* , 2005, Journal of Biological Chemistry.

[11]  E. Baldoni,et al.  Diabetes and periodontal disease: a case-control study. , 2005, Journal of periodontology.

[12]  M. Granić,et al.  CPITN assessment of periodontal disease in diabetic patients. , 1988, Journal of periodontology.

[13]  J. Bidwell,et al.  Osteoblast Apoptosis and Bone Turnover , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  G. Taylor,et al.  Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. , 2002, Community dentistry and oral epidemiology.

[15]  H. Löe Periodontal Disease: The sixth complication of diabetes mellitus , 1993, Diabetes Care.

[16]  L. Niskanen,et al.  Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. , 1998, Journal of periodontology.

[17]  R. Genco,et al.  Periodontal disease in non-insulin-dependent diabetes mellitus. , 1991, Journal of periodontology.

[18]  T. Kislinger,et al.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.

[19]  L. Golub,et al.  MMP‐Mediated Events in Diabetes , 1999, Annals of the New York Academy of Sciences.

[20]  M. Moss,et al.  Effects of occlusal attrition and continuous eruption on odontometry of rat molars. , 1977, American journal of physical anthropology.

[21]  N. Bissada,et al.  Long term effect of systemic tetracycline administration on the severity of induced periodontitis in the rat. , 1979, Journal of periodontology.

[22]  J. Osredkar,et al.  Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. , 2003, Journal of periodontal research.

[23]  D. Graves,et al.  Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. , 2004, The Journal of investigative dermatology.

[24]  R. Arnold,et al.  Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. , 1997, Journal of clinical periodontology.

[25]  P. Romano,et al.  The reversal line may be a key modulator of osteoblast function: observations from an alveolar bone wound-healing model. , 1997, Journal of periodontal research.

[26]  M. Bezerra,et al.  Low-dose doxycycline prevents inflammatory bone resorption in rats. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  T. Tachikawa,et al.  Participation of periodontal ligament cells with regeneration of alveolar bone. , 2001, Journal of periodontology.

[28]  D. Graves,et al.  IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. , 1998, Journal of immunology.

[29]  S. Socransky,et al.  Microbial complexes in subgingival plaque. , 1998, Journal of clinical periodontology.

[30]  Louis C Gerstenfeld,et al.  Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. , 2004, Endocrinology.

[31]  D. Graves,et al.  Apoptotic Effects of LPS on Fibroblasts are Indirectly Mediated through TNFR1 , 2004, Journal of dental research.

[32]  D. Graves,et al.  Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. , 2002, The Journal of infectious diseases.

[33]  I. Lamster,et al.  Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. , 2004, Journal of periodontology.